IBM closed the books on its first quarter of 2026 with a result that did exactly what Arvind Krishna has been promising Wall Street for two years: software and infrastructure both grew double digits, margins expanded, and free cash flow climbed past the $2 billion mark. The Armonk-based company reported $15.9 billion in revenue for the quarter ended March 31, 2026, up 9% as reported and 6% at constant currency, beating the Wall Street consensus of roughly $15.8 billion and pushing operating EPS to $1.91, comfortably above the $1.81 analysts had modeled.
The April 22, 2026 release marks IBM’s eighth straight quarter of accelerating software growth and the strongest infrastructure print since the z16 mainframe cycle peaked in 2023. Yet the after-hours reaction was muted, even slightly negative – a reminder that for a stock up more than 50% over the past year, “good” is no longer good enough. This analysis breaks down the numbers, the segment dynamics behind them, the generative AI book of business that now sits at the center of IBM’s investment narrative, and what the result means for the broader enterprise software market heading into a fully booked AI capex cycle.
Don't miss new tech stories on Google
Add Tech Insider once in the Google app and our stories appear in your news suggestions.
The Headline Numbers: $15.9 Billion in Revenue and a 9% Beat
IBM’s top-line number – $15.92 billion, up 9% year over year from the $14.5 billion IBM reported for Q1 2025 – is the company’s fastest reported growth rate in any first quarter since the spin-off of Kyndryl in November 2021. At constant currency the figure is 6%, suggesting roughly 300 basis points of tailwind from a weaker U.S. dollar against the euro and yen during the quarter. That currency benefit is real cash, but it also means underlying organic momentum is closer to the mid-single digits than the headline implies. The acceleration was not a one-quarter blip: IBM’s quarterly revenue had already climbed to $17.0 billion by Q2 2025, according to the company’s July 2025 report, showing the growth trajectory behind this print had been building for well over a year.
GAAP diluted EPS from continuing operations came in at $1.28, up from $1.12 a year earlier, while non-GAAP operating EPS reached $1.91, up from $1.60 – a 19% year-over-year jump. Free cash flow for the quarter was $2.2 billion, up from the $2.0 billion IBM reported for Q1 2025, and net cash from operating activities was $5.2 billion, up $800 million from the $4.4 billion IBM posted in the year-ago quarter. IBM ended the quarter with $10.9 billion in cash and equivalents on the balance sheet and returned $1.6 billion to shareholders in dividends.
“The first quarter was a strong start to the year with broad-based revenue growth across our segments,” CEO Arvind Krishna said in the earnings release. “AI continues to be a tailwind for our global business, expanding the relevance of our hybrid cloud and AI strategy with clients.”
Software Segment: $7.1 Billion and 11% Growth Powered by Red Hat and Automation
Software remained the engine of the quarter, posting $7.1 billion in revenue, up 11% as reported and 8% at constant currency. The segment now represents roughly 45% of total IBM revenue, up from 42% a year ago, and the mix shift continues to drag the company’s blended gross margin higher. Software gross margins typically run in the high-70s to low-80s range, compared with high-30s for infrastructure and low-30s for consulting.
Within software, Red Hat continues to be the standout. Red Hat’s Linux, OpenShift, and Ansible portfolio has been growing at a low-teens pace for six consecutive quarters, fueled by enterprise GenAI workloads that need a portable, on-prem-compatible Kubernetes substrate. The HashiCorp acquisition, which closed in February 2025 for $6.4 billion, contributed a full quarter of revenue for the second time and added meaningfully to the Automation sub-segment. Transaction Processing – the legacy CICS and IMS workloads tied to mainframe – also benefited from a fresh wave of pricing actions tied to the new z17 cycle.
Consulting Stays Soft: 4% Reported Growth, 1% at Constant Currency
The weakest spot in the quarter was Consulting, which grew just 4% as reported to roughly $5.3 billion and only 1% at constant currency. Discretionary IT services spending across financial services and telco verticals remains under pressure as enterprises reroute budgets into AI agent pilots rather than long-tail digital transformation projects. Accenture, Capgemini, Cognizant, and Infosys have all flagged similar sluggishness in calendar Q1.
The bright spot inside Consulting is the generative AI book of business, where IBM is now booking incremental services dollars as a follow-on to watsonx licensing. The company has historically split its AI book roughly two-thirds Consulting, one-third Software, although that mix is gradually shifting in favor of Software as inference workloads scale. Investors will want a clearer breakdown on the call, but pre-release commentary suggests the consulting share of AI bookings is now closer to 60% than 70%.
Infrastructure’s 15% Surge: The z17 Mainframe Cycle Arrives
Infrastructure was the upside surprise of the quarter, growing 15% as reported and 12% at constant currency to about $3.3 billion. The driver is the new IBM z17 mainframe, which began shipping in mid-2025 and is now in the heaviest part of its installation curve. Mainframe cycles historically follow a 2-3 year up-down pattern, with the first four to six quarters after launch delivering 25-30% segment growth before the comparison base resets.
What is different this cycle is the AI co-processor story. The z17 ships with on-chip Telum II accelerators that can run inference for fraud detection, claims adjudication, and trade settlement at the same low-latency tier as the underlying transaction. Banks and insurers – IBM’s largest mainframe customer base – are upgrading earlier than usual to put generative scoring models inside the same security perimeter as the data, rather than shipping payloads to a public cloud GPU. That dynamic is showing up in MIPS shipments, which IBM has not disclosed but which channel checks suggest are running 20-25% above the equivalent z16 quarter.
Q1 2026 Earnings Snapshot: All the Key Numbers
| Metric | Q1 2026 | Q1 2025 | YoY Change |
|---|---|---|---|
| Total Revenue | $15.92B | $14.54B | +9% reported / +6% CC |
| Software Revenue | $7.1B | $6.4B | +11% reported / +8% CC |
| Consulting Revenue | $5.3B | $5.1B | +4% reported / +1% CC |
| Infrastructure Revenue | $3.3B | $2.9B | +15% reported / +12% CC |
| GAAP Gross Margin | 56.2% | 55.2% | +100 bps |
| Non-GAAP Gross Margin | 57.7% | 56.6% | +110 bps |
| GAAP Diluted EPS | $1.28 | $1.12 | +14% |
| Operating (Non-GAAP) EPS | $1.91 | $1.60 | +19% |
| Free Cash Flow | $2.2B | $1.9B | +$0.3B |
| Cash & Equivalents | $10.9B | $13.5B | -$2.6B |
| Dividends Returned | $1.6B | $1.5B | +$0.1B |
The Generative AI Book of Business: Inside IBM’s $7+ Billion Pipeline
The single most-watched metric in any IBM quarter is no longer the mainframe upgrade rate or even the Red Hat growth number – it is the cumulative inception-to-date book of business for generative AI. IBM first disclosed the figure in October 2023 at “more than $1 billion.” By Q4 2025 it had crossed $7 billion. Wall Street is modeling Q1 2026 commentary in the $7.5 to $8.5 billion range, a quarter-over-quarter add of roughly $500 million to $1.5 billion in new bookings.
The number matters because it is the cleanest available proxy for how successfully a legacy enterprise vendor is converting AI hype into signed contracts. By comparison, Microsoft has disclosed annualized GenAI run-rates above $13 billion across Copilot and Azure OpenAI, while Salesforce has guided Agentforce to a more modest several-hundred-million ramp. IBM’s mix of two-thirds services, one-third software is the inverse of the hyperscalers, and that ratio is what determines whether the book ultimately produces software-like margins or services-like margins as it converts to revenue.
Margin Expansion: 110 Basis Points of Non-GAAP Gross Profit Lift
Non-GAAP gross margin expanded 110 basis points to 57.7% in the quarter, the eighth consecutive quarter of expansion and the highest first-quarter print in IBM’s modern history. Three forces are at work: software mix shift (highest-margin segment grew fastest), Red Hat operating use (subscription revenue now scales without proportional headcount), and consulting utilization (post-pandemic bench rationalization is finally flowing through to gross profit).
Non-GAAP pre-tax income margin expanded an even more impressive 140 basis points to 13.4%, suggesting operating expense discipline is intact even as IBM continues to invest in watsonx, the Granite open-source model family, and its quantum roadmap. Adjusted EBITDA reached $4.0 billion for the quarter, up from $3.4 billion in Q1 2025, putting the trailing-twelve-month figure on track to exceed $17 billion for the first time; by comparison, adjusted EBITDA had already reached $4.7 billion in Q2 2025 alone, per IBM’s July 2025 report, a reminder of how quickly the margin story built through last year.
Free Cash Flow: $2.2 Billion in Q1 and a $14B+ Full-Year Trajectory
Free cash flow of $2.2 billion in the quarter is the strongest Q1 IBM has reported since 2018. Q1 is seasonally the smallest cash-flow quarter for IBM (large software billings hit in Q4), so a $2.2 billion print is consistent with full-year free cash flow comfortably above $13.5 billion and arguably approaching $14 billion if the second half tracks plan. Management formally reiterated the prior outlook of “approximately $1 billion of free cash flow growth year over year” – implying $14.0 billion against the 2025 base of $12.7 billion.
The cash conversion story is what underwrites the dividend, the buyback capacity, and the M&A firepower. IBM raised the quarterly dividend from $1.67 to $1.69 per share in late April 2026, marking the 31st consecutive annual increase – one of the longest streaks in the S&P 500. Including the Q1 dividend payout, total capital returned in the quarter was $1.6 billion, with no material share repurchases as IBM continues to digest the HashiCorp acquisition.
Full-Year 2026 Guidance: Reaffirmed at “Above 5%” Constant-Currency Growth
Management reaffirmed full-year 2026 guidance: more than 5% revenue growth at constant currency and approximately $1 billion year-over-year increase in free cash flow. Including the recent dollar weakness, reported revenue growth is now likely to land in the 7-8% range, putting full-year revenue on a path to approximately $69-70 billion against 2025’s $65 billion. That confidence is grounded in a 2025 base that was already strengthening quarter over quarter – non-GAAP operating pre-tax income hit $3.2 billion in Q2 2025 alone, per IBM’s July 2025 report – giving management a higher floor to guide from heading into 2026.
CFO James Kavanaugh framed the outlook as deliberately conservative. “Given this solid start, we maintain our expectation of over 5 percent growth in revenue at constant currency and anticipate an increase of around $1 billion in free cash flow year over year for 2026,” Kavanaugh said in the release. The decision not to raise the official top-line range – despite a 9% reported Q1 – reflects two factors: a tougher infrastructure compare in Q3 as the z17 cycle laps itself, and conservatism around consulting demand in the second half.
Stock Reaction: Why a Beat-and-Reaffirm Wasn’t Enough
Despite the headline beat, IBM shares traded modestly lower in the after-hours session immediately following the release. The stock had run up sharply ahead of the print – up roughly 12% in the trailing month and more than 50% over the prior year – leaving the bar for an unambiguous “beat-and-raise” exceptionally high. A reaffirmation of full-year guidance, rather than the formal raise some sell-side analysts had begun modeling in mid-April, was enough to trigger profit-taking from short-term holders.
That said, the longer-term setup remains constructive. IBM trades at roughly 22-23x calendar 2026 operating EPS, a meaningful premium to its 10-year average of 14x but a discount to the broader large-cap software complex, which trades closer to 30x. The compression in that valuation gap over the past 18 months is the single best summary of how the market has re-rated IBM’s transformation.
Analyst Reaction: Cautious Optimism From the Sell Side
Pre-release sell-side commentary was incrementally positive across the board. Wedbush analyst Daniel Ives, one of the more vocal IBM bulls, has highlighted the generative AI book of business as the cleanest signal that “Krishna’s bet on hybrid cloud + AI is converting into bookings, not just slideware.” Bernstein’s Toni Sacconaghi has been more measured, flagging the consulting deceleration as the single biggest swing factor for the back half of the year.
Citi, Morgan Stanley, and JPMorgan all carried Buy or Overweight ratings into the print with price targets in the $290-$320 range against a pre-earnings stock price in the mid-$280s. Bank of America’s Wamsi Mohan was the most cautious among the bulge-bracket names, citing valuation, while UBS upgraded the stock to Neutral from Sell in early April after the company’s analyst day reset the bear case on consulting.
Competitive Context: How IBM Stacks Up Against Microsoft, Oracle, and Accenture
The cleanest competitive frame for IBM in 2026 is no longer the legacy “big iron” cohort but the new hybrid AI infrastructure cohort, where IBM competes for enterprise wallet share against Microsoft (Azure + Copilot), Oracle (OCI + database), and Accenture (services). Each of those peers is approaching the same opportunity from a different starting point.
| Company | Most Recent Quarter | Reported Revenue | YoY Growth | GenAI Disclosure |
|---|---|---|---|---|
| IBM | Q1 CY2026 | $15.9B | +9% | Inception-to-date GenAI book ~$7-8B |
| Microsoft | FY26 Q2 (Dec 2025) | ~$72B | ~13% | $13B+ annualized AI run-rate |
| Oracle | FY26 Q3 (Feb 2026) | ~$15B | ~10% | $155B+ RPO including OpenAI deal |
| Accenture | FY26 Q2 (Feb 2026) | ~$17B | +5% | ~$5B GenAI bookings since inception |
| SAP | Q1 CY2026 | ~€9B | +11% | Cloud backlog ~€20B with AI uplift |
The takeaway: IBM’s reported growth rate is now within shouting distance of Microsoft on a constant-currency basis, even though its absolute revenue base is roughly one-fifth the size. The gap between IBM’s $7B-plus inception-to-date GenAI book and Microsoft’s $13B annualized AI run-rate is real, but it has compressed materially over the past four quarters as IBM’s services-led approach catches up with the hyperscaler-led approach inside Fortune 500 procurement cycles.
Historical Context: From the Ginni Rometty Trough to the Krishna Re-Rating
To appreciate why the Q1 2026 print matters, it helps to remember where IBM was in 2019. Revenue had declined for 22 consecutive quarters, the stock had spent most of the decade flat, and the company was widely characterized as a slow-motion melting ice cube. Ginni Rometty’s $34 billion acquisition of Red Hat in 2019 was the bet that paid for the turnaround; her successor Arvind Krishna’s decision in 2021 to spin off the managed infrastructure services business as Kyndryl was what allowed the remaining IBM to be valued as a software-and-AI company rather than a services-and-hardware company.
The financial result of that surgery is now visible: IBM’s mix of software is approaching 50% of revenue, gross margins have moved from the low-50s to the high-50s, and free cash flow is on track for an all-time record in 2026. Earnings power has followed the same arc – non-GAAP operating EPS, which stood at $1.91 in Q1 2026, had already climbed to $2.80 in the seasonally stronger Q2 2025 quarter, according to IBM’s July 2025 report, underscoring how much profitability has scaled since the Kyndryl spin-off. Five years after Krishna took over, the stock has roughly doubled and outperformed the S&P 500 on a total-return basis over the trailing two years.
Five Predictions for IBM Through the Rest of 2026
With Q1 in the books and full-year guidance reaffirmed, the next four quarters will be defined by five testable predictions:
- 1. The GenAI book of business will exceed $12 billion by Q4 2026. Quarterly net adds have been accelerating since Q3 2024, and the average deal size is rising as customers move from pilots to production. A $4-5 billion full-year add looks achievable.
- 2. Software will reach 50% of total revenue by year-end. The combination of Red Hat double-digit growth, HashiCorp annualization, and watsonx ramp will pull software past the symbolic milestone for the first time in IBM history.
- 3. IBM will raise full-year guidance at the Q2 print in July 2026. The Q1 beat plus continued FX tailwinds make the current “above 5%” guide look stale. Expect a formal raise to “above 6%” constant currency.
- 4. A new $5B+ acquisition will land before year-end. With $10.9B of cash and roughly $1.6B/quarter of dividend obligation, IBM has the firepower for another HashiCorp-scale deal – likely in the AI agent infrastructure or vertical AI space.
- 5. The stock will re-rate to 25-26x forward EPS within twelve months. If software mix continues to climb and the GenAI book sustains its run-rate, the historical valuation discount to the broader software complex will compress further.
Risks and Watch Items: What Could Derail the Story
The bull case is not without risk. The single biggest swing factor remains consulting demand. A sustained reacceleration in IT services across financial services and manufacturing is required to keep the segment from becoming a 0-2% growth drag on the consolidated top line. Currency is the second variable: roughly half of IBM’s revenue is generated outside the United States, and a sharp dollar reversal would compress the reported growth rate by 200-300 basis points.
Mainframe seasonality is the third. The z17 cycle is in its sweet spot now, but Q3 and Q4 will start to face tougher comparisons against the launch quarters of mid-2025. Infrastructure growth is therefore likely to decelerate from 15% reported in Q1 to mid-single-digits by Q4, which the market has already partly priced in. Finally, the GenAI book of business itself is a disclosure metric, not a GAAP revenue line – a slowdown in net adds would be interpreted by the market as a leading indicator of broader enterprise AI fatigue.
What It Means for the Broader Enterprise Software Market
IBM’s Q1 print is one of the cleanest data points yet that enterprise AI spending is converting from pilot budgets into permanent line items in 2026. The 11% software growth, 15% infrastructure growth, and continued GenAI book expansion together suggest that the so-called “GenAI revenue cliff” feared by SaaS bears in late 2025 has not materialized – at least not for vendors with credible hybrid stories.
For peers, the read-through is mixed. Microsoft’s late-April earnings will be the next major datapoint, and IBM’s strength in Red Hat / OpenShift suggests that hyperscale lock-in is being mitigated by enterprises actively choosing portable Kubernetes substrates. For pure-play SaaS names – Salesforce, ServiceNow, Workday, Snowflake – IBM’s services-led conversion model is something of a warning shot: when the buyer is a Fortune 500 CIO trying to deploy AI agents inside a regulated workflow, services attach rates matter more than product velocity.
Frequently Asked Questions
What was IBM’s Q1 2026 revenue?
IBM reported $15.9 billion in revenue for Q1 2026, up 9% year over year as reported and 6% at constant currency, beating the Wall Street consensus of approximately $15.8 billion.
How much did IBM earn per share in Q1 2026?
GAAP diluted earnings per share were $1.28, while non-GAAP operating EPS was $1.91, beating the $1.81 consensus and growing 19% year over year from $1.60 in Q1 2025.
How fast is IBM’s software business growing?
Software grew 11% as reported in Q1 2026 (8% at constant currency) to roughly $7.1 billion. Red Hat continues to lead the segment with low-teens growth, while HashiCorp is now contributing a full quarter to the Automation sub-segment.
How big is IBM’s generative AI book of business?
The cumulative inception-to-date book of business for generative AI crossed $7 billion in Q4 2025 and is widely modeled to reach $7.5-8.5 billion as of Q1 2026 commentary, with roughly two-thirds of the bookings coming through Consulting and one-third through Software.
What is IBM’s full-year 2026 guidance?
IBM reaffirmed its outlook of more than 5% revenue growth at constant currency and approximately $1 billion year-over-year growth in free cash flow, implying free cash flow of approximately $14 billion against $12.7 billion in 2025.
Why did IBM stock drop after the Q1 2026 earnings beat?
The stock had rallied roughly 12% in the month leading into the print and over 50% in the trailing year, leaving the bar exceptionally high. A reaffirmation of full-year guidance – rather than the formal raise some investors expected – triggered profit-taking from short-term holders despite the EPS and revenue beats.
How does IBM’s growth compare to Microsoft and Oracle?
IBM’s 9% reported revenue growth trails Microsoft’s roughly 13% growth in its most recent quarter but is in line with Oracle’s approximately 10% pace. IBM’s GenAI book of business is smaller in absolute terms than Microsoft’s $13 billion annualized AI run-rate but has been growing faster sequentially.
Is the IBM dividend safe?
Yes. IBM raised its quarterly dividend from $1.67 to $1.69 in late April 2026, marking the 31st consecutive annual increase. The trailing-twelve-month free cash flow of approximately $13 billion comfortably covers the roughly $6.5 billion annual dividend obligation.
Where can I find IBM’s official Q1 2026 results?
The official release is published on the IBM Newsroom and the live earnings call recording is available on the IBM Investor Relations events page.
Additional reporting and historical financials for IBM are available from FactSet Earnings Insight, CNBC quote pages, the Red Hat investor portal, and ZDNet IBM coverage.
